Nicholson Price @nicholson.bsky.social · 23/06/2026As #AI is used in medicine, there's a push to monitor it better for safety/performance, including by @fda.gov. In a new piece in Columbia Sci Tech L Rev, I canvas those arguments & argue we need more: learning for improvement—not just safety. journals.library.columbia.edu/index.php/st... #lawsky 001
Nicholson Price @nicholson.bsky.social · 04/05/2026I had heard of the Wilson et al @science.org paper that people prefer to give themselves mild electric shocks than be alone with their own thoughts, but I'd never read it. It's wild! Anyway, back to pondering, I guess. Maybe I'll read instead. www.science.org/doi/10.1126/... #psych #science 140
Nicholson Price @nicholson.bsky.social · 01/05/2026Has anyone else been getting janky post-peer-review reviewer letters from @springernature.com journals? As in, I review something, and eventually I get a letter saying what the decision was...but there's no decision. Is this just me? NBD, but curious... #academia 000
Nicholson Price @nicholson.bsky.social · 20/04/2026In a response to @kaytesb.bsky.social, G. Lenarczyk, H.L. Smith & I argue industry research partnerships can be valuable but fickle, & not necessarily countercyclical. We look to the nascent European Health Data Space for governance ideas. www.tandfonline.com/doi/full/10.... #healthdata #governance 012
Nicholson Price @nicholson.bsky.social · 20/04/2026With federal science $$ 📉, whence support for research? @kaytesb.bsky.social has a great Am. J. Bioethics piece on the promise, risk, & institutional governance of academic/industrial partnerships, w/ lessons from genetic data. www.tandfonline.com/doi/full/10.... @michiganbioethics.bsky.social 112
Nicholson Price @nicholson.bsky.social · 09/03/2026Surprisingly, AI performance mattered most! Performing "better than a specialist" increased patient choice of an encounter by 36%! And trust by 0.68 (on a 1-5 scale). Clinician presence increased preference 18%; different forms of governance by ~10% each (FDA, natl or local certification) /2 110
Nicholson Price @nicholson.bsky.social · 20/02/2026The 5Q is based on my recent @emorylawjournal.bsky.social piece, "Clinicians in the Loop of Medical AI," which says LOTS about the problems of asking clinicians to oversee #medical #AI and what we should think about instead. papers.ssrn.com/sol3/papers..... #lawtwitter 010
Nicholson Price @nicholson.bsky.social · 29/10/2025OK that is a VERY effective fake text. Almost got me! But if you bake cookies at @umichlaw.bsky.social, I already have your number in my phone. (But if this is @mchannon.bsky.social from a burner phone, yes, I would like cookies please.) 040
Nicholson Price @nicholson.bsky.social · 23/06/2025Genomic data: neat! But also super sensitive! How can people get their own genomes analyzed without sharing stuff they don't want to? Jake Sherkow of Illinois Law presents a neat technical approach and argues that yep, patent law can enable it. At Copenhagen Law at #ATRIP25 (in dramatic light!) 0121
Nicholson Price @nicholson.bsky.social · 05/06/2025What court cases are reshaping FDA? ACLA v FDA: FDA can't regulate lab-developed tests. SEC v Jarkesy: Can FDA impose civil monetary penalties re: tobacco? Corner Post: How many old FDA decisions can be challenged? Amazing #ASLME2025: @pzettler.bsky.social, @rachelsachs.bsky.social, Lewis Grossman 181
Nicholson Price @nicholson.bsky.social · 08/01/2025This is woefully insufficient for what you need, but just in case it's useful, this is a bit I ginned up for my heavy-reading seminars. I also point them to Paul Edward's 2000 How to Read a Book, available (among other places) here: www.cs.yorku.ca/~aboelaze/ho... #lawsky #academia #legalacademia 160
